miR-33 as a Therapeutic Target for the Metabolic Syndrome

被引：0
|
作者：
Salerno, Alessandro G. [1 ]
Ramirez, Cristina M. [1 ]
Goedeke, Leigh [1 ]
Wanschel, Amarylis C. [1 ]
Esau, Christine C. [2 ]
Moore, Kathryn [1 ]
Suarez, Yajaira [1 ]
Fernandez-Hernando, Carlos [1 ]
机构：
[1] Leon H Charney Div Cardiol, Dept Med, New York, NY USA
[2] Regulus Therapeut, Dept Med, San Diego, CA USA
来源：
CIRCULATION | 2011年 / 124卷 / 21期
关键词：
Lipoproteins; Molecular biology;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16635
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Macrophage Specific Regulatory Role of miR-33 in Pulmonary Fibrosis
    Ahangari, F.
    Chioccioli, M.
    Malik, S.
    Baernthaler, T.
    Price, N.
    Ding, S.
    Rose, K.
    Mcdonough, J. E.
    Omote, N.
    Schupp, J. C.
    Adams, T.
    Sharma, L.
    DeIuliis, G.
    Dela Cruz, C.
    Prasse, A.
    Bahal, R.
    Fernandez-Hernando, C.
    Kaminski, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [22] Mir-33 regulates cell proliferation and cell cycle progression
    Cirera-Salinas, Daniel
    Pauta, Montse
    Allen, Ryan M.
    Salerno, Alessandro G.
    Ramirez, Cristina M.
    Chamorro-Jorganes, Aranzazu
    Wanschel, Amarylis C.
    Lasuncion, Miguel A.
    Morales-Ruiz, Manuel
    Suarez, Yajaira
    Baldan, Angel
    Esplugues, Enric
    Fernandez-Hernando, Carlos
    CELL CYCLE, 2012, 11 (05) : 922 - 933
  • [23] MiR-33 may be a Biological Marker for Coronary Heart Disease
    Xie, Zezhou
    Ma, Peipei
    CLINICAL LABORATORY, 2018, 64 (10) : 1755 - 1760
  • [24] miR-33 regulates GABAergic mechanisms of fear-inducing memories
    Radulovic, J.
    Meyer, M.
    Corcoran, K.
    Jovasevic, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S535 - S535
  • [25] Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis
    Price, Nathan L.
    Zhang, Xinbo
    Fernandez-Tussy, Pablo
    Singh, Abhishek K.
    Burnap, Sean A.
    Rotllan, Noemi
    Goedeke, Leigh
    Sun, Jonathan
    Canfran-Duque, Alberto
    Aryal, Binod
    Mayr, Manuel
    Suarez, Yajaira
    Fernandez-Hernando, Carlos
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (05)
  • [26] Anti-atherosclerosis or No Anti-atherosclerosis That is the miR-33 question
    Naeaer, Anders M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (03) : 447 - 448
  • [27] Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice
    Goedeke, Leigh
    Salerno, Alessandro
    Ramirez, Cristina M.
    Guo, Liang
    Allen, Ryan M.
    Yin, Xiaoke
    Langley, Sarah R.
    Esau, Christine
    Wanschel, Amarylis
    Fisher, Edward A.
    Suarez, Yajaira
    Baldan, Angel
    Mayr, Manuel
    Fernandez-Hernando, Carlos
    EMBO MOLECULAR MEDICINE, 2014, 6 (09) : 1133 - 1141
  • [28] Myostatin: a potential therapeutic target for metabolic syndrome
    Yang, Ming
    Liu, Chongbin
    Jiang, Na
    Liu, Yan
    Luo, Shilu
    Li, Chenrui
    Zhao, Hao
    Han, Yachun
    Chen, Wei
    Li, Li
    Xiao, Li
    Sun, Lin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [29] Adipocytokines: Emerging therapeutic target for metabolic syndrome
    Matsuzawa, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 301 - 301
  • [30] New therapeutic target for metabolic syndrome:: PPARδ
    Takahashi, Sadao
    Tanaka, Toshiya
    Sakai, Juro
    ENDOCRINE JOURNAL, 2007, 54 (03) : 347 - 357
12345